Le Lézard
Classified in: Business
Subjects: FNC, ACC

Loomis signs a 2-year Term Loan facility of EUR 115 million


STOCKHOLM, Oct. 2, 2023 /PRNewswire/ -- Loomis AB has signed an agreement for a syndicated Term Loan facility of EUR 115 million. The facility has a tenor of up to two years.

The facility can be used for general corporate purposes of the Group, including acquisitions.

The arrangers are Bank of America, Danske Bank and Nordea Bank.

This press release is also available on the company's website, www.loomis.com

October 2, 2023

CONTACT:

Jenny Boström
Head of Sustainability and IR
Mobile: +46 79 006 45 92
Email: [email protected]

The following files are available for download:

https://mb.cision.com/Main/51/3846262/2332752.pdf

Loomis signs a 2-year Term Loan facility of EUR 115 million

 

SOURCE Loomis AB


These press releases may also interest you

at 22:00
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...

at 21:35
Foundry 415 Innovation Group Launches Startup BoostCamp: A Workshop Series to Accelerate Startup Growth and Success
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....

at 21:05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Primerica, Inc. - PRI
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...

at 21:01
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 21:00
ZIMLog Unveils Transformed Structure and Expanded Scope Pioneering the Future of Logistics with reliable and Personalized Precision
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful...

at 20:55
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...

More news about Business...


News published on and distributed by: